Skip to main content
Clinical Trials/NCT00772733
NCT00772733
Completed
Not Applicable

A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment

AstraZeneca1 site in 1 country936 target enrollmentOctober 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COPD
Sponsor
AstraZeneca
Enrollment
936
Locations
1
Primary Endpoint
Control visits at General practitioners
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The purpose of this study is to ensure the quality of the COPD treatment in primary care by implementing planned follow-up visits, where the disease condition is evaluated and optimised in accordance with the national COPD recommendations. If relevant the general practitioner (GP) will refer patients to COPD rehabilitation conducted by relevant municipality rehabilitation teams. Secondarily the purpose is to improve collaboration and communication between the local hospital pulmonologist, GPs and the municipality rehabilitation team

Registry
clinicaltrials.gov
Start Date
October 2008
End Date
December 2010
Last Updated
15 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • COPD diagnose, verified by spirometry
  • Having given informed consent

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Control visits at General practitioners

Time Frame: 6-12 months

Lung function measured by spirometry

Time Frame: 6-12 months

Secondary Outcomes

  • Dyspnoea on MRC scale(6-12 months)
  • Smoking status(6-12 months)
  • Rehabilitation completed in the municipality rehabilitation team(6-12 months)

Study Sites (1)

Loading locations...

Similar Trials